A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.
Clinical trial NCT07251062 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07251062
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2029-12-30
- Enrollment
- 737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.